Why is Mono Pharmacare falling/rising?

As of 10-Jun, Mono Pharmacare Ltd is experiencing a decline in its stock price, currently at 24.25, which represents a decrease of 1.2 or 4.72%. The stock has underperformed its sector today by 5.24%, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has dropped by 4.90%, while it has seen a modest increase of 0.62% over the past month. However, year-to-date, the stock has significantly underperformed with a decline of 30.01%. Notably, there has been a rise in investor participation, with delivery volume increasing by 138.1% against the 5-day average, indicating some interest despite the overall negative performance. Unfortunately, there is no information available regarding positive or negative factors affecting the stock.
In the broader market context, Mono Pharmacare's recent performance contrasts sharply with the benchmark index, Sensex, which has gained 2.29% over the past week and 4.57% over the past month. Year-to-date, while the stock has plummeted by 30.01%, the Sensex has risen by 6.17%. This disparity highlights the stock's struggles relative to the overall market, suggesting that investor sentiment towards Mono Pharmacare is weak compared to the broader market trends.